MedPath

Observational Study With Investigation of Two Second Generation Laryngeal Masks

Completed
Conditions
Airway Remodeling
Interventions
Device: Success
Registration Number
NCT02566291
Lead Sponsor
Johannes Gutenberg University Mainz
Brief Summary

In a observational study the second-generation laryngeal masks LMA Supreme and Ambu AuraGain are investigated.

Detailed Description

After approval from the local ethics committee, data were collected in a prospective, non- randomised study over a three-month period. When contra-indications for laryngeal mask use were absent anaesthesiologists used either Supreme (Teleflex Medical GmbH, Germany) or Gain (Ambu GmbH, Germany). Endpoints were the success rate and time to insertion.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
364
Inclusion Criteria
  • Age ≄ 18 Years
  • No concurrent participation in another study
  • capacity to consent
  • Present written informed consent of the research participant
  • Elective surgery under general anesthesia
Exclusion Criteria
  • Age <18 years
  • Existing pregnancy
  • Lack of consent
  • inability to consent
  • emergency patients
  • Emergency situations in the context of a Difficult Airway Management
  • ASA classification> 3
  • situations where the possibility of accumulated gastric contents
  • Participation in another study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Supreme GroupSuccessMeasuring Success rate and Insertion Time
Gain GroupSuccessMeasuring Success rate and Insertion Time
Primary Outcome Measures
NameTimeMethod
Success rate70-98 Percent

overall and first attempt success rate

Secondary Outcome Measures
NameTimeMethod
Time for insertion5-120 seconds
Leakage in ml.min0-300 ml.min

Trial Locations

Locations (1)

Department of Anaesthesiology;

šŸ‡©šŸ‡Ŗ

Mainz, Rhineland-Palatinate, Germany

Ā© Copyright 2025. All Rights Reserved by MedPath